TokenPost·
AnaptysBio Shares Fall 7.74% During GSK-Tesaro Post-Trial Hearing
-7.74%
AnaptysBio share drop
GSK’s U.S. depositary shares closed 2.37% higher on Oct. 20. A ruling in the Jemperli rights dispute is expected by early 2027.
More news
- TokenPostAlpha Teknova Prices $40 Million Offering After 22.9% Share Drop
- CoinGapeSolana’s Alpenglow Goes Live, Aiming for 40x Faster Finality as Votes Move Off-Chain
- TokenPostAnnaly Swings to $1 Billion Q3 Loss as Book Value Drops
- TokenPostSpaceX Digital Asset Value Drops $64 Million Since Year-End 2025
- TokenPostRollins, Inc. Raises Quarterly Dividend 9.6% to $0.20 a Share
- Crypto BriefingBlackRock CEO Larry Fink warns data center delays could raise costs and inflation